Drugs Containing Excipient (Inactive Ingredient) CITRIC ACID

Branded drugs containing CITRIC ACID excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
A-S Medication Solutions	DELSYM	dextromethorphan	50090-0224	CITRIC ACID
HJ Harkins Company Inc	TRANSMUCOSAL FENTANYL CITRATE	fentanyl citrate	52959-549	CITRIC ACID
Aytu BioPharma Inc	TUZISTRA XR	codeine polistirex and chlorpheniramine polistirex	69654-480	CITRIC ACID ACETATE	2027-03-15
Zhuhai Beihai Biotech Co Ltd	BEIZRAY	docetaxel	83513-009	CITRIC ACID ACETATE
Rebel Distributors Corp	ZOMIG	zolmitriptan	21695-955	CITRIC ACID ANHYDROUS
ER Squibb & Sons LLC	HYDREA	hydroxyurea	0003-0830	CITRIC ACID MONOHYDRATE
ER Squibb & Sons LLC	DROXIA	hydroxyurea	0003-6336	CITRIC ACID MONOHYDRATE

Generic drugs containing CITRIC ACID excipient

Company	Ingredient	NDC	Excipient
PAI Holdings LLC dba PAI Pharma	brivaracetam	0121-1074	CITRIC ACID
Rebel Distributors Corp	fluocinonide	21695-207	CITRIC ACID
Rebel Distributors Corp	prednisolone	21695-365	CITRIC ACID
Rebel Distributors Corp.	amoxicillin and clavulanate potassium	21695-401	CITRIC ACID
Rebel Distributors Corp	ibuprofen	21695-420	CITRIC ACID
Rebel Distributors Corp	flurbiprofen sodium	21695-615	CITRIC ACID
Rebel Distributors Corp	cefaclor	21695-782	CITRIC ACID

Market Dynamics and Financial Trajectory for Citric Acid in the Pharmaceutical Excipient Sector

Last updated: March 23, 2026

What are the key drivers influencing the demand for citric acid in pharmaceuticals?

The global pharmaceutical excipient market for citric acid is driven by the following factors:

• Increasing pharmaceutical production: The expansion of injectables, syrups, and effervescent tablets uses citric acid as a pH adjuster and stabilizer.
• Growth in consumer health products: Nutraceuticals and functional foods incorporate citric acid, indirectly impacting pharmaceutical-grade demand.
• Regulatory acceptance: Citric acid’s Generally Recognized as Safe (GRAS) status facilitates its use in medicinal formulations.
• Consumer preferences: Shift toward natural, biodegradable excipients elevates citric acid’s market position over synthetic alternatives.

How does the supply chain influence market stability and pricing?

• Sourcing and raw material costs: The primary raw material, fermentation-derived sugars, face volatility in prices due to seasonal and geopolitical factors.
• Manufacturing capacities: Established producers in China, the U.S., and Europe dominate supply, with China accounting for approximately 70% of global production[1].
• Trade policies: Export restrictions and tariffs influence global availability and pricing dynamics.
• Environmental regulations: Stringent waste management and emission standards impact production costs.

What are the current market size and forecast trends?

Parameter	2022	2027 (Projected)	CAGR (2022-2027)
Market size (USD billion)	~$250 million	~$340 million	7.5%
Production volume (metric tons)	~375,000	~520,000	7.2%
Price per metric ton (USD)	~$670	~$650	-0.3% (slight decline)

Growth is driven by active pharmaceutical ingredient (API) formulations, with demand increasing at a compound annual growth rate (CAGR) of 7.5% over five years. Price stabilization or slight decline reflects advancements in fermentation tech and increased capacity.

How do regional markets differ?

• Asia-Pacific: Dominates manufacturing, driven by China’s significant share. Prices tend to be lower due to economies of scale.
• North America: Focused on high-quality, compliant formulations, with stable supply chains and higher prices.
• Europe: Emphasizes regulatory compliance and organic sourcing, leading to premium pricing.

What are the critical regulatory and technological factors?

• Regulatory approvals: Citric acid is approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for pharmaceutical excipient use.
• Quality standards: Pharmacopeia standards (USP, EP, JP) dictate purity, affecting market inclusiveness.
• Manufacturing innovations: Advances in microbial fermentation increase yield, reduce costs, and improve environmental footprint.

What are competitive forces and market challenges?

• Market players: Major producers include Jungbunzlauer, Cargill, and ADM, collectively controlling about 60-70% of the market.
• Price competition: Overcapacity in China leads to aggressive pricing strategies.
• Environmental concerns: Stricter emissions standards increase costs for fermentation-based producers.
• Innovation needs: To counter commoditization, firms focus on sustainable sourcing and cleaner production methods.

What is the financial outlook for stakeholders?

• Profit margins: Gross margins range from 15%-30%, with premium pricing attainable in regulated markets.
• Investment trends: Capital expenditure focuses on expanding fermentation capacity and upgrading quality control.
• Return on Investment (ROI): Ranges between 10-15% for new capacity projects over five years.
• Mergers and acquisitions: Market consolidation occurs as firms seek to expand capacity or enter new regional markets.

Key Takeaways

• Demand for citric acid in pharmaceuticals grows at a CAGR of approximately 7.5%, driven by production expansion and regulatory acceptance.
• China supplies about 70% of global capacity, exerting influence on pricing and supply stability.
• Price trends show slight declines or stabilization, with capacity expansion enabling competitive pricing.
• Regional disparities exist, with Asia-Pacific dominating manufacturing and North America/Europe emphasizing compliance and quality.
• Market challenges include overcapacity, environmental regulations, and the need for technological innovation.

FAQs

1. What is the primary application of citric acid in pharmaceuticals?
It acts as a pH stabilizer, buffering agent, and excipient in formulations such as effervescent tablets, syrups, and injectable solutions.

2. How does regulation affect citric acid’s market?
Regulatory approvals by agencies like the FDA and EMA enable wide use in pharmaceuticals, influencing acceptance and market expansion.

3. What technological advances impact citric acid production?
Improvements in fermentation efficiency, bioprocessing, and sustainable manufacturing practices reduce costs and environmental impact.

4. How do geopolitical factors influence citric acid supply?
Trade restrictions, tariffs, and export controls in major producing countries like China affect global supply chains and pricing stability.

5. What are the prospects for new entrants in the citric acid pharmaceutical excipient market?
New entrants face high barriers due to established supply chain dominance, regulatory requirements, and significant capital investment in fermentation capacity.

---

References

[1] MarketWatch. (2023). Global citric acid market overview.